A Pragmatic Utility Function to Describe the Risk-Benefit
It is not straightforward to simultaneously evaluate the beneficial and harmful effects of pain management, since different drugs may possess different analgesia and adverse effect profiles. Utility functions, derived from the pharmacokinetics and pharmacodynamics of individual outcome parameters, have been constructed to address this problem. Here, we construct “pragmatic” utility functions based on measurements of benefit and harm, but without making assumptions about the underlying pharmacokinetics and pharmacodynamics. Using data from two previous studies, utility functions were designed by estimating the probability of occurrence of benefit and harm and combining these into one function. Study 1 was a clinical trial on the effect of oral pregabalin on pain relief in chronic pancreatitis patients, with endpoint analgesia and dizziness monitored for 21 days. Study 2 was an experimental study on the effect of intravenous fentanyl on antinociception and respiratory depression in healthy volunteers. From study 1, the utility function was negative the first week of treatment, indicative of the greater probability of dizziness than analgesia, but positive thereafter. From study 2, the utility function showed a nadir 30 minutes after dosing, after which the probability function slowly increased toward zero. A pragmatic utility function based on the probability of two binary outcomes, analgesia and adverse effect, was successfully constructed using data from the two previous studies. The results yielded valuable insights into the utility of treatment and may be highly educative for physicians and potentially used in development of potent analgesics without serious side effects.
11.1: App. B: Utility Functions AI Safety, Ethics, and Society Textbook
A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
Risk-based benefit-cost analysis of ecosystem-based disaster risk reduction with considerations of co-benefits, equity, and sustainability - ScienceDirect
Total cost of risk
046 Whose pain are we treating? A study comparing ED patients' expectations of analgesia with ED doctors' preconceptions
Logic model of Case 1 co-created intervention mechanism. QOL = quality
A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
11.1: App. B: Utility Functions AI Safety, Ethics, and Society Textbook
A Pragmatic Utility Function to Describe the Risk-Benefit Composite of Opioid and Nonopioid Analgesic Medication
Assessment of pain associated with chronic pancreatitis: An international consensus guideline - ScienceDirect
PDF) Neuropathic Pain: Challenges and Opportunities
Current Oncology, Free Full-Text